Find the Perfect Plan for Your Investment Journey
C
Latest price
52 Week Range
A$246.14 - A$350.31
Next Earnings Date
Aug 13 2025 (Estimate)
Next Earnings Date
Aug 13 2025 (Est.)
Latest price
Market Cap | A$17.31B |
EV | A$17.17B |
Shares Outstanding | 65.43M |
Beta | 0.38 |
Analyst Rating | HOLD |
Analyst Target Price | A$286.83 |
P/E 2025E | 42.25x |
P/Revenue 2025E | 7.19x |
Revenue | 14.80% |
EPS | 17.90% |
Operating Cash Flow | 12.70% |
Free Cash Flow | 12.40% |
Revenue | 9.00% |
EPS | 11.00% |
Operating Cash Flow | 15.80% |
Free Cash Flow | 12.20% |
Gross Margin 2025E | 74.71% |
Net Profit Margin 2025E | 17.03% |
ROE 2025E | 21.94% |
ROCE 2024 | 19.88% |
DPS 2025E | A$4.40 |
Payout Ratio 2025E | 70.06% |
Div. Yield 2025E | 1.65% |
DPS Last 3Y CAGR | 17.20% |
Price
%
1M
3M
6M
1Y
3Y
5Y
C
Cochlear Limited
COH
Sector
Healthcare
Industry
Medical - Devices
CEO
Howitt, Diggory
Employees
5,047
Website
www.cochlear.comIPO Date
1995-12-31
Headquarters
1 University Avenue, Macquarie University, Sydney, New South Wales, 2109, Australia
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved